Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ

K-Number: K850832 · 1985-03-29

ApplicantOxoid U.S.A., Inc.
Decision Date1985-03-29
Product CodeJSJ
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ is the device name listed in this FDA 510(k) record. The listed applicant is Oxoid U.S.A., Inc.. It received FDA 510(k) clearance on 1985-03-29 under 510(k) number K850832. The device is classified under product code JSJ. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ?

CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ is a medical device that received FDA 510(k) clearance on 1985-03-29. The listed applicant is Oxoid U.S.A., Inc.. The 510(k) number is K850832.

When did CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ receive FDA 510(k) clearance?

CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ received FDA 510(k) clearance on 1985-03-29, under 510(k) number K850832.

Who is the listed applicant for CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ?

The FDA 510(k) record lists Oxoid U.S.A., Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ?

The FDA product code for CAMPYLOBACTER BLOOD-FREE SELECTIVE AGAR BASEQ is JSJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Oxoid U.S.A., Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K891593LISTERIA SELECTIVE ENRICHMENT MEDIUMK884026ESCHERICHIA COLI 0157 LATEX AGGLUTINATION TEST KITK884208LISTERIA SELECTIVE MEDIUM (OXFORD FORMULATION)K874303STAPHYLASE TESTK872956SORBITOL MACCONKEY AGAR NO. 3 CM 813K872135MCBRIDE MEDIUM CM 819

View all 93 devices →

Related Devices (Code: JSJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K882463POTATO DEXTROSE AGAR (PDA) - PRODUCT #P3421Lakewood Biochemical Co., Inc.K881544LITTMAN AGARAcumedia Manufacturers, Inc.K881561TERGITOL 7 BROTHAcumedia Manufacturers, Inc.K881526CHAPMAN STONE MEDIUMAcumedia Manufacturers, Inc.K881571YM BROTHAcumedia Manufacturers, Inc.K881578STREPTOSELAcumedia Manufacturers, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑